On the other hand, among DEP upregulated in exosomes of good responders was PON1, an important antioxidant enzyme, which elevated serum level was previously observed in rectal cancer patients in response to neoadjuvant radiochemotherapy [15]. This evidence concerns the gene PON1 and rectal cancer.